Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

2.

Tumor cell dissemination patterns and metastasis of murine mammary carcinoma.

Juacaba SF, Horak E, Price JE, Tarin D.

Cancer Res. 1989 Feb 1;49(3):570-5.

3.

Vascular dissemination of tumor cells in relation to temperature-dependent metastasis in frogs.

Juacaba SF, McKinnell RG, Hanson WJ, Tarin D.

J Natl Cancer Inst. 1987 Feb;78(2):259-64.

PMID:
3492623
4.

Collagenase secretion by human breast neoplasms: a clinicopathologic investigation.

Ogilvie DJ, Hailey JA, Juacaba SF, Lee EC, Tarin D.

J Natl Cancer Inst. 1985 Jan;74(1):19-27.

PMID:
2982053
5.
6.

Observations on organ distribution of fluorescein-labelled tumour cells released intravascularly.

Potter KM, Juacaba SF, Price JE, Tarin D.

Invasion Metastasis. 1983;3(4):221-33.

PMID:
6429082

Supplemental Content

Loading ...
Support Center